Last update 27 Nov 2024

Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
EpCAM
Mechanism
EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Colonic CancerEpCAM positive Solid TumorsEsophageal Carcinoma+ [4]
Originator Organization
The First Affiliated Hospital of Chengdu Medical College
Active Organization
The First Affiliated Hospital of Chengdu Medical College
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)
NCT03013712 / Unknown statusPhase 1/2IIT
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
100 Clinical Results associated with Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)
Login to view more data
100 Translational Medicine associated with Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)
Login to view more data
100 Patents (Medical) associated with Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)
Login to view more data
100 Deals associated with Anti-EPCAM CAR-T (The First Affiliated Hospital of Chengdu Medical College)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colonic CancerPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
EpCAM positive Solid TumorsPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
Esophageal CarcinomaPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
Hepatocellular CarcinomaPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
Pancreatic CancerPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
Prostatic CancerPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
Stomach CancerPhase 2
CN
The First Affiliated Hospital of Chengdu Medical College
01 Jan 2017
NeoplasmsPhase 2-
The First Affiliated Hospital of Chengdu Medical College
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free